HER-2 Testing in Breast Cancer Using Immunohistochemical Analysis and Fluorescence In Situ Hybridization : A Single-Institution Experience of 2,279 Cases and Comparison of Dual-Color and Single-Color Scoring
- 1 May 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 121 (5) , 631-636
- https://doi.org/10.1309/ve78-62v2-646b-r6ex
Abstract
We analyzed concordance between immunohisto-chemical analysis and fluorescence in situ hybridization (FISH) in HER-2 status and studied the effect of dual-color (D-FISH) vs single-color FISH (S-FISH) scoring on the assignment of tumors to amplified or nonamplified categories. The assays were performed on formalin-fixed, paraffin-embedded sections of 2,279 invasive breast carcinomas. Immunohistochemical results were interpreted as negative (0, 1+) or positive (2+, 3+). For FISH analyses, a ratio for HER-2/chromosome 17 of 2.0 or more (D-FISH) or an absolute HER-2 copy number per nucleus of more than 4.0 (S-FISH) were interpreted as positive gene amplification.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas without HER-2/neu Gene AmplificationThe Journal of Molecular Diagnostics, 2003
- Comparison of Fluorescence and Chromogenic In Situ Hybridization for Detection of HER-2/neu Oncogene in Breast CancerAmerican Journal of Clinical Pathology, 2003
- HER2 Assessment by Immunohistochemical Analysis and Fluorescence In Situ HybridizationAmerican Journal of Clinical Pathology, 2002
- Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast CancerJournal of Clinical Oncology, 2002
- Her-2/ neu and Breast CancerDiagnostic Molecular Pathology, 2001
- Prognostic and predictive factors in breast cancerCancer Treatment Reviews, 2001
- Quantitative Evaluation of HER-2/neuStatus in Breast Cancer by Fluorescence In Situ Hybridization and by Immunohistochemistry With Image AnalysisAmerican Journal of Clinical Pathology, 2001
- Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assaysJournal of Clinical Pathology, 2000
- The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A reviewGene, 1995
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987